HCA-HEALTHCARE (1HCA.MI)
Milan - Milan Delayed price. Currency in EUR
Add to watchlist
At close: 03:30PM CEST
| Previous close | 300.20 |
| Open | 289.20 |
| Bid | 294.70 x N/A |
| Ask | 297.30 x N/A |
| Day's range | 289.20 - 289.20 |
| 52-week range | 223.20 - 319.00 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 25 July 2024 - 29 July 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Business WireHCA Healthcare, Inc. to Present at June Healthcare Conference
NASHVILLE, Tenn., May 10, 2024--HCA Healthcare, Inc. (NYSE:HCA), is scheduled to present at the following healthcare conference:
GlobeNewswireAREX Capital Expresses Disappointment in Enhabit’s Strategic Review Conclusion
Believes Enhabit’s Shares Do Not Reflect its Intrinsic Value or Strategic Potential Has Nominated Seven Highly Qualified Independent Directors Believes AREX Slate Would Provide Board With Sorely Needed Home Health and Hospice Expertise NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- AREX Capital Management, LP (“AREX Capital Management” or “we”), together with its affiliates, the owners of approximately 4.8% of the shares of Enhabit, Inc. (NYSE: EHAB) (the “Company” or “Enhabit”), today issued the be
Simply Wall St.HCA Healthcare First Quarter 2024 Earnings: Beats Expectations
HCA Healthcare ( NYSE:HCA ) First Quarter 2024 Results Key Financial Results Revenue: US$17.3b (up 11% from 1Q 2023...
© 2024 Yahoo. All rights reserved.